The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus

International Journal of Surgery - Tập 20 - Trang 8-16 - 2015
Zong-ming Zhang1, Eric C. H. Lai2, Chong Zhang1, Hongwei Yu1, Zhuo Liu1, Bo-jiang Wan1, Limin Liu1, Zu-Hao Tian1, Hai Deng1, Qiuhong Sun1, Xiaoping Chen3
1Department of General Surgery, Beijing Electric Power Hospital, Capital Medical University, Beijing, China.
2Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Chaiwan, Hong Kong, China
3Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Torre, 2015, Global cancer statistics, 2012, CA Cancer J. Clin., 65, 87, 10.3322/caac.21262

Takizawa, 2007, Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis, Dig. Dis. Sci., 52, 3290, 10.1007/s10620-007-9808-2

Lin, 2011, An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus, J. Cancer Res. Clin. Oncol., 137, 139, 10.1007/s00432-010-0868-x

Cheng, 2007, Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein, Hepatogastroenterology, 54, 499

Shi, 2011, A new classification for hepatocellular carcinoma portal vein tumor thrombus, J. Hepatobiliary Pancreat. Sci., 18, 74, 10.1007/s00534-010-0314-0

Peng, 2012, Surgical treatment of hepatocellular carcinoma complicated with portal vein tumor thrombus, Chin. J. Bases Clin. Gen. Surg., 19, 237

Liu, 2014, Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis, Ann. Surg. Oncol., 21, 1825, 10.1245/s10434-014-3510-3

Chok, 2014, Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis, World J. Surg., 38, 490, 10.1007/s00268-013-2290-4

Li, 2013, Hepatocellular carcinoma patients with left portal vein tumor thrombus may benefit from left hemi-hepatectomy with caudate lobectomy, Hepatogastroenterology, 60, 1451

Tang, 2013, Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study, World J. Surg., 37, 1362, 10.1007/s00268-013-1969-x

Kashiwazaki, 2013, Resection and postoperative multidisciplinary treatment for hepatocellular carcinoma with massive portal venous tumor thrombus-a single-center experience, Gan Kagaku Ryoho, 40, 1675

Peng, 2012, Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus, Cancer, 118, 4725, 10.1002/cncr.26561

Zhou, 2011, Prognostic analysis for treatment modalities in hepatocellular carcinomas with portal vein tumor thrombi, Asian Pac J. Cancer Prev., 12, 2847

Wu, 2011, Combined three-dimensional conformal radiotherapy plus transcatheter arterial chemoembolization and surgical intervention for portal vein tumor thrombus in patients with hepatocellular carcinoma, Zhonghua Yi Xue Za Zhi, 91, 2841

Shi, 2010, Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus, Ann. Surg. Oncol., 17, 2073, 10.1245/s10434-010-0940-4

Peng, 2009, Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus, Am. J. Surg., 198, 313, 10.1016/j.amjsurg.2008.09.026

Liang, 2008, Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy, World J. Surg., 32, 627, 10.1007/s00268-007-9364-0

Chen, 2006, Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma, Ann. Surg. Oncol., 13, 940, 10.1245/ASO.2006.08.007

Schwarz, 2010, American Hepato-Pancreato-Biliary association; society of surgical oncology; society for surgery of the alimentary tract, nonoperarive therapies for combined modality treatment of hepatocelular cancer: expect consensus statement, HPB (Oxford), 12, 313, 10.1111/j.1477-2574.2010.00183.x

Matsui, 2010, Interventional oncology: new options for interstitial treatments and intravascular approaches: superselective TACE using iodized oil for HCC: rationale, technique and outcome, J. Hepatobiliary Pancreat. Sci., 17, 407, 10.1007/s00534-009-0234-z

Kim, 2009, Transcatheter arterial chemoembolization vs chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis, Aliment. Pharmacol. Ther., 29, 1291, 10.1111/j.1365-2036.2009.04016.x

Chen, 2010, Elucidating therapeutic effects on patients with hepatocellular carcinoma and main portal vein thrombosis, Hepatogastroenterology, 57, 228

Hirooka, 2010, Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus, Am. J. Roentgenol., 194, W221, 10.2214/AJR.09.2852

Kuroda, 2007, Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma, Hepatogastroenterology, 54, 518

Kulik, 2008, Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis, Hepatology, 47, 71, 10.1002/hep.21980

Tsai, 2010, Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis, J. Vasc. Interv. Radiol., 21, 1377, 10.1016/j.jvir.2010.04.027

Iñarrairaegui, 2012, Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma, Eur. J. Surg. Oncol., 38, 594, 10.1016/j.ejso.2012.02.189

Saxena, 2014, Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: a single centre experience of 45 consecutive patients, Int. J. Surg., 12, 1403, 10.1016/j.ijsu.2014.07.269

Ettorre, 2014, Downstaging hepatocellular carcinoma with Yttrium-90 radioembolization: resection or transplantation?, Eur. J. Surg. Oncol., 40, 789, 10.1016/j.ejso.2014.01.017

Izaki, 2004, Transcatheter arterial embolization for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complicating hepatocellular carcinoma, Radiat. Med., 22, 155

Zhang, 2009, Color doppler guided percutaneous oily chemoembolization for the treatment of portal vein tumor thrombus in HCC patients, Chin. J. Interv. Imaging Ther., 6, 167

Pan, 2004, Percutaneous transhepatic portal vein tube insertion and chemotherapy under ultrasonographic guide in the treatment of 38 hepatocellular carcinoma patients with portal vein tumor thrombus, Clin. Med. J. China, 11, 565

Cui, 2012, Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients, Asian Pac. J. Cancer Prev., 13, 6257, 10.7314/APJCP.2012.13.12.6257

Zheng, 2013, A three year-followed up of patients with hepatocellular carcinoma complicated by portal vein tumor thrombus receiving TACE and PVC after resection of tumors, J. Clin. Hepatol., 16, 351

Huang, 2013, Clinical evaluation of double interventional therapy combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus, China Foreign Med. Treat., 32, 94

Fu, 2010, 3-Dimentional conformal hypofractionated radiotherapy for Portal vein tumor thrombus in patients with hepatocellular carcinoma, Pract. J. Cancer, 25, 295

Nakagawa, 2005, Radiation therapy for portal venous invasion by hepatocellular carcinoma, World J. Gastroenterol., 11, 7237, 10.3748/wjg.v11.i46.7237

Rim, 2012, Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis, Jpn. J. Clin. Oncol., 42, 721, 10.1093/jjco/hys082

Zhang, 2009, Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization, Cancer, 115, 1245, 10.1002/cncr.24139

Potters, 2010, Int. J. Radiat. Oncol. Biol. Phys., 76, 326, 10.1016/j.ijrobp.2009.09.042

Que, 2014, The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities, Radiat. Oncol., 9, 120, 10.1186/1748-717X-9-120

Sanuki, 2014, Role of stereotactic body radiation therapy for hepatocellular carcinoma, World J. Gastroenterol., 20, 3100, 10.3748/wjg.v20.i12.3100

Ibarra, 2012, Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors, Acta Oncol., 51, 575, 10.3109/0284186X.2011.652736

Ling, 2012, Proton therapy for hepatocellular carcinoma, Chin. J. Cancer Res., 24, 361, 10.1007/s11670-012-0276-7

Hata, 2005, Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus, Cancer, 104, 794, 10.1002/cncr.21237

Sugahara, 2009, Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis, Strahlenther. Onkol., 185, 782, 10.1007/s00066-009-2020-x

Kawashima, 2011, Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 79, 1479, 10.1016/j.ijrobp.2009.12.048

Lee, 2014, Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis, Strahlenther. Onkol., 190, 806, 10.1007/s00066-014-0604-6

Yang, 2014, Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial, J. Cancer Res. Clin. Oncol., 140, 211, 10.1007/s00432-013-1568-0

Zheng, 2014, Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?, Clin. Radiol., 69, e253, 10.1016/j.crad.2014.01.015

Cui, 2005, Percutaneous portal vein chemoembolization in the treatment of primary hepatic carcinoma with portal vein tumor thrombus, China Oncol., 15, 381

Ishikawa, 2014, Percutaneous transhepatic portal vein stent placement can improve prognosis for hepatocellular carcinoma patients with portal vein tumor thrombosis, Hepatogastroenterology, 61, 413

Luo, 2011, Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein, J. Vasc. Interv. Radiol., 22, 479, 10.1016/j.jvir.2010.11.029

Ming, 2009, Portal vein stenting combined with transcatheter hepatic arterial chemoembolization in treatment of portal vein tumor thrombus in patients with primary hepatic carcinoma, J. Med. Imaging, 19, 298

Giorgio, 2009, Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?, Am. J. Roentgenol., 193, 948, 10.2214/AJR.08.2087

Cheng, 2000, An experimental ultrasonic disruption in the treatment of intraportal thrombi of liver cancer, Chin. J. General Surg., 15, 24

Mearini, 2013, High intensity focused ultrasound , liver disease and bridging therapy, World J. Gastroenterol., 19, 7494, 10.3748/wjg.v19.i43.7494

Qiu, 2013, The effects of high intensity focused ultrasound therapy combined with transcatheter hepatic arterial chemoembolization on the patients with hepatocellular carcinoma with portal vein tumor thrombus, Jiangxi Med. J., 48, 1174

Katagiri, 2014, Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus, Surg. Today, 44, 219, 10.1007/s00595-013-0585-6

Simpson, 2008, Sorafenib: in hepatocellular carcinoma, Drugs, 68, 251, 10.2165/00003495-200868020-00007

Kane, 2009, Sorafenib for the treatment of unresectable hepatocellular carcinoma, Oncologist, 14, 95, 10.1634/theoncologist.2008-0185

Jeong, 2013, Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis, Gut Liver, 7, 696, 10.5009/gnl.2013.7.6.696

Kermiche-Rahali, 2013, Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib, World J. Surg. Oncol., 11, 171, 10.1186/1477-7819-11-171

Irtan, 2011, Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection, Liver Int., 31, 740, 10.1111/j.1478-3231.2010.02441.x